GGrantIndex
Sort

11,323 grants matching glioblastoma

Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM

$348,526
Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2025 · NS

Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence

$348,514
Peter D Canoll · Columbia University Health Sciences · R01 · FY2020 · NS

Overcoming therapy resistance in GBM

$348,418
Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2012 · CA

Overcoming Barriers of Virotherapy by Next-Generation oHSV Expressing E-Cadherin

$348,382
Jianhua Yu · Ohio State University · R01 · FY2018 · NS

A SIGNALING PATHWAY SPECIFIC FOR ALKYLATION DAMAGE

$348,363
Nima Mosammaparast · Washington University · R01 · FY2019 · CA

RNAi screen of the glioblastoma stem cell kinome under hypoxia and normoxia

$348,305
Brent H. Cochran · Tufts University Boston · R01 · FY2013 · NS

Project 1: Arming Oncolytic HSV Vectors to Improve Virolysis in Syngeneic Mouse Models of GBM

$348,274
Joseph C. Glorioso · Brigham And Women'S Hospital · P01 · FY2022 · CA

In vivo imaging of encapsulated stem cells in mouse models of tumor resection

$348,272
Khalid A Shah · Massachusetts General Hospital · R01 · FY2014 · CA

Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence

$348,258
Peter D Canoll · Columbia University Health Sciences · R01 · FY2017 · NS

The Role of CK2 in Glioblastoma Development

$348,244
Etty N. Benveniste · University Of Alabama At Birmingham · R01 · FY2016 · CA

Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence

$348,236
Peter D Canoll · Columbia University Health Sciences · R01 · FY2018 · NS

Single cell analysis of the infiltrative margins of glioblastoma and post-treatment recurrence

$348,234
Peter D Canoll · Columbia University Health Sciences · R01 · FY2019 · NS

Generating a Systemic Immune Response Using Localized Delivery of Chemotherapy in Brain Tumors

$348,202
Michael Lim · Stanford University · R01 · FY2024 · CA

Core 1: Biospecimens Core

$348,162
Jann N Sarkaria · Massachusetts Institute Of Technology · U54 · FY2023 · CA

Cytoplasmic Multimerization of the RNA-binding protein HuR is Oncogenic in Glioma

$348,129
Louis B Nabors · University Of Alabama At Birmingham · R01 · FY2016 · CA

Brain Cancer Radio-Pathomics for Predicting Heterogeneous Cytology

$348,075
Peter S Laviolette · Medical College Of Wisconsin · R01 · FY2017 · CA

Identifying Early Failure to Anti-angiogenic Therapy in Recurrent GBM

$348,040
Eva-Maria Ratai · Massachusetts General Hospital · R01 · FY2017 · CA

Identifying Early Failure to Anti-angiogenic Therapy in Recurrent GBM

$348,040
Eva-Maria Ratai · Massachusetts General Hospital · R01 · FY2018 · CA

Identifying Early Failure to Anti-angiogenic Therapy in Recurrent GBM

$348,040
Eva-Maria Ratai · Massachusetts General Hospital · R01 · FY2015 · CA

Identifying Early Failure to Anti-angiogenic Therapy in Recurrent GBM

$348,040
Eva-Maria Ratai · Massachusetts General Hospital · R01 · FY2016 · CA

Biguanide Sensitivity of Glioma Stem Cells

$347,942
Biplab Dasgupta · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · NS

STINGing GBM: A First-in- Man Clinical Trial in Surgical Resectable Recurrent GBM

$347,923
Amy Beth Heimberger · Northwestern University At Chicago · P50 · FY2025 · CA

Connexins and glioblastoma progression

$347,898
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · NS

Connexins and glioblastoma progression

$347,898
Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · NS

Tissue-Engineered Models of Glioblastoma for Evaluating Treatment Response

$347,894
Stephanie Kristin Seidlits · University Of Texas At Austin · R01 · FY2023 · CA